JWH-018 binds to both the CB1 and CB2 receptors. The effects of JWH-018 are generally attributable on the binding and activation of CB1 receptors. In exercise, the compound suppresses the discharge of neurotransmitters in the central anxious program, which explains the large number of consequences.